A multicenter study of recombinant interferon-alpha 2b in the treatment of multibacillary leprosy.
Ganapati
R
R
Pai
V V
VV
Banerji
U
U
Thomas
J
J
Saha
B
B
D002991:Clofazimine / Q000008:administration & dosage / Q000627:therapeutic use; D003622:Dapsone / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004890:Erythema / Q000175:diagnosis; D006801:Humans; D007370:Interferon Type I / Q000008:administration & dosage / Q000627:therapeutic use*; D007916:Lepromin / Q000032:analysis / Q000187:drug effects; D007917:Leprostatic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015440:Leprosy, Lepromatous / Q000188:drug therapy*; D011994:Recombinant Proteins; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use
D007370:Interferon Type I; D007917:Leprostatic Agents; D011994:Recombinant Proteins; D007916:Lepromin; D003622:Dapsone; D002991:Clofazimine; D012293:Rifampin